Armas Pharmaceuticals Pharmaceutical Import Profile — United States (DGFT 2022–2026)

Name: Armas Pharmaceuticals Pharmaceutical Import Records from India — 3 Products, $11.6M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Armas Pharmaceuticals — Pharmaceutical Importer Profile (2026) | 3 Products, $11.6M Trade | TransData Nexus

Armas Pharmaceuticals

Pharmaceutical Importer · United States · Antibiotics Focus · $11.6M Total Trade · DGFT Verified

Armas Pharmaceuticals is a pharmaceutical importer based in United States with a total trade value of $11.6M across 3 products in 2 therapeutic categories. Based on 231 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Armas Pharmaceuticals sources from 3 verified Indian suppliers, with Steriscience Specialties Private Limited accounting for 86.7% of imports.

Armas Pharmaceuticals — Import Portfolio & Supplier Network

Armas Pharmaceuticals import network — 3 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Armas Pharmaceuticals?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Steriscience Specialties Private Limited	$10.8M	227	86.7%
Brooks Steriscience Limited	$911.1K	22	7.3%
Onesource Specialty Pharma Limited	$750.0K	15

What Formulations Does Armas Pharmaceuticals Import?

Formulation	Value	Ships
Piperacillin & tazobactam for	$1.5M	31
Ampicillin & sulbactam for injection	$350.0K	7
Ampicillin for injection USP 2g-batch	$350.0K	7
Oxacillin for injection USP 2g/vial	$228.5K	7
Ampicillin & suibactam for injection	$150.0K	3
Oxacillian for injection USP 2g/vial	$143.9K	6
2000001323, meropenem for injection usp1g/vial, batch no. 5500063a, mfg dt 04.2024 exp.dt 03.2026 (56960 pac)	$130.4K	3
Ampicillin sulbactum for injection USP 2g 1g 10 s batch no 5200282 Pack size 2793x10s	$100.0K	2
Ampicillin sulbactum for injection USP 2g 1g 10 s batch no 5200277 Pack size 2728x10s	$100.0K	2
Ampicillin sulbactum for injection USP 2g 1g 10 s batch no 5200286 Pack size 2601x10s	$100.0K	2
Ampicillin sulbactum for injection USP 2g 1g 10 s batch no 5200285 Pack size 2601x10s	$100.0K	2
Piperacillin tazobactam for injectionusp 3 0g 0 375g batch no 5200279 Pack size 4875x10s	$100.0K	2
Piperacillin tazobactam for injectionusp 3 0g 0 375g batch no 5200278 Pack size 4831x10s	$100.0K	2
Piperacillin & tazobactam for injectionusp4.0g/0.5g Pack size3678x10s	$100.0K	2
Piperacillin & tazobactam for injectionusp4.0g/0.5g Pack size3568x10s	$100.0K	2

Armas Pharmaceuticals imports 186 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Ampicillin	Antibiotics	$7.3M	145	5.1%	2
2	Piperacillin	Advanced Antibiotics	$3.2M	64	3.6%	3
3	Meropenem	Advanced Antibiotics	$1.1M	22	0.5%	17

Armas Pharmaceuticals imports 3 pharmaceutical products across 2 categories into United States totaling $11.6M.

Armas Pharmaceuticals — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Armas Pharmaceuticals is a specialty pharmaceutical company headquartered in Freehold, New Jersey. Established in 2018, the company focuses on delivering a portfolio of high-quality generic injectable medications, including oncology-related products. Armas Pharmaceuticals emphasizes fostering industry relationships and creating strong global partnerships to expand its product offerings.

The company's leadership team comprises individuals with extensive experience in the pharmaceutical industry. John Niemi, the Executive Chairman and Founder, has nearly 37 years of experience, including roles at Faulding Pharmaceuticals, Cura Pharmaceuticals, Sagent Pharmaceuticals, and Amneal Pharmaceuticals. Joe Niemi serves as the President & CEO, bringing over two decades of experience in commercial sales, business development, and organizational leadership.

Armas Pharmaceuticals plays a significant role in the United States pharmaceutical distribution network by sourcing and importing generic injectable medications from international suppliers, particularly from India. This strategy enables the company to offer a diverse range of products to meet the needs of healthcare providers and patients across the country.

2Distribution Network

Armas Pharmaceuticals operates a distribution network that ensures the efficient delivery of pharmaceutical products throughout the United States. While specific warehouse locations are not publicly disclosed, the company's logistics capabilities are designed to support nationwide coverage. By leveraging strategic partnerships and a robust supply chain, Armas Pharmaceuticals aims to provide consistent and timely access to its product portfolio for healthcare providers and patients across the country.

3Industry Role

In the United States pharmaceutical supply chain, Armas Pharmaceuticals functions as a pharmaceutical importer and distributor. By sourcing generic injectable medications from international suppliers, particularly from India, the company plays a crucial role in enhancing the availability and affordability of essential medications. This position allows Armas Pharmaceuticals to serve as a key intermediary between foreign manufacturers and the U.S. healthcare market, ensuring that high-quality pharmaceutical products are accessible to healthcare providers and patients nationwide.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Armas Pharmaceuticals

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Armas Pharmaceuticals demonstrates a high degree of supplier concentration, with 86.7% of its imports from India sourced from STERISCIENCE SPECIALTIES PRIVATE LIMITED. This significant reliance on a single supplier indicates a strategic choice to maintain a consistent and reliable supply chain. However, such concentration also introduces potential risks, including supply disruptions due to geopolitical issues, regulatory changes, or operational challenges faced by the supplier. The company's decision to diversify its supplier base, as evidenced by partnerships with BROOKS STERISCIENCE LIMITED and ONESOURCE SPECIALTY PHARMA LIMITED, suggests a proactive approach to mitigating these risks and ensuring the stability of its product offerings.

2Supply Chain Resilience

Armas Pharmaceuticals' supply chain resilience is bolstered by its partnerships with multiple Indian suppliers, including STERISCIENCE SPECIALTIES PRIVATE LIMITED, BROOKS STERISCIENCE LIMITED, and ONESOURCE SPECIALTY PHARMA LIMITED. This diversification strategy enhances the company's ability to adapt to potential disruptions and maintain a steady product supply. The importation of 186 unique pharmaceutical formulations further indicates a broad sourcing strategy, reducing dependency on any single product line. While specific details regarding shipping routes and regulatory compliance of key suppliers are not publicly available, Armas Pharmaceuticals' established relationships with reputable suppliers suggest adherence to international quality standards and regulatory requirements.

Importing Pharmaceuticals into United States — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United States

1Regulatory Authority & Framework

In the United States, the Food and Drug Administration (FDA) serves as the primary regulatory authority overseeing the importation and distribution of pharmaceutical products. The FDA enforces the Federal Food, Drug, and Cosmetic Act (FD&C Act), which sets forth requirements for the safety, efficacy, and quality of drugs imported into the U.S. Pharmaceutical importers must ensure that their products comply with FDA regulations, including those related to labeling, manufacturing practices, and clinical testing. The FDA's import program involves coordination with U.S. Customs to review and determine the admissibility of imported drugs, ensuring they meet the necessary standards before entering the U.S. market.

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products entering the United States are governed by the FDA. Importers must file an entry notice and an entry bond with U.S. Customs, notifying the FDA of the product's arrival. The FDA reviews these entries to determine the admissibility of the products, ensuring they comply with the FD&C Act and related regulations. Good Manufacturing Practice (GMP) certification is a critical component of this process. The FDA recognizes GMP certifications from reputable international bodies, including the European Union (EU) GMP, World Health Organization (WHO) GMP, and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). Pharmaceutical products imported into the U.S. must be manufactured in facilities that adhere to these recognized GMP standards to ensure product quality and safety.

Armas Pharmaceuticals — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Armas Pharmaceuticals' product strategy focuses on importing generic injectable medications, with a particular emphasis on antibiotics and advanced antibiotics. This focus aligns with the company's mission to provide essential medications that address critical healthcare needs. The market demand for these products is driven by the ongoing prevalence of bacterial infections and the need for effective treatments in both hospital and outpatient settings. By sourcing these products from reputable international suppliers, Armas Pharmaceuticals aims to ensure a consistent and affordable supply of high-quality medications to the U.S. market.

2Sourcing Profile

Armas Pharmaceuticals employs a sourcing strategy that prioritizes generic drug formulations, particularly in the antibiotic and advanced antibiotic categories. This approach allows the company to offer a diverse and cost-effective product portfolio, meeting the needs of healthcare providers and patients. India's status as a major global supplier of affordable therapeutics makes it a strategic partner for Armas Pharmaceuticals, enabling the company to leverage India's manufacturing capabilities and regulatory compliance to enhance its product offerings.

3Market Positioning

Seller's Guide — How to Become a Supplier to Armas Pharmaceuticals

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to partner with Armas Pharmaceuticals. The company's focus on importing generic injectable medications, particularly in the antibiotic and advanced antibiotic categories, presents a niche market segment that Indian exporters can target. By meeting Armas Pharmaceuticals' quality standards and regulatory requirements, Indian suppliers can establish a foothold in the U.S. market, expanding their reach and contributing to the diversification of Armas Pharmaceuticals' product portfolio.

2Requirements & Qualifications

Indian exporters seeking to supply Armas Pharmaceuticals and the U.S. market must adhere to specific certifications, quality standards, and regulatory approvals. Products must be manufactured in facilities that comply with recognized Good Manufacturing Practice (GMP) standards, such as those set by the European Union (EU) GMP

TransData Nexus Research · Industry procurement practicesMar 2026

Frequently Asked Questions — Armas Pharmaceuticals

What products does Armas Pharmaceuticals import from India?

Armas Pharmaceuticals imports 3 pharmaceutical products across 2 categories. Top imports: Ampicillin ($7.3M), Piperacillin ($3.2M), Meropenem ($1.1M).

Who supplies pharmaceuticals to Armas Pharmaceuticals from India?

Armas Pharmaceuticals sources from 3 verified Indian suppliers. The primary supplier is Steriscience Specialties Private Limited (86.7% of imports, $10.8M).

What is Armas Pharmaceuticals's total pharmaceutical import value?

Armas Pharmaceuticals's total pharmaceutical import value from India is $11.6M, based on 231 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Armas Pharmaceuticals focus on?

Armas Pharmaceuticals imports across 2 categories. The largest: Antibiotics (62.8%), Advanced Antibiotics (37.2%).

Get Full Armas Pharmaceuticals Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.